NCI-Funded Research at the 2024 San Antonio Breast Cancer Symposium December 10-13

Date Posted

For those participating in the 2024 Symposium, consider attending these sessions to learn about the latest from DCP-funded research from NCORP and the Grand Challenges Program.

Check out the full online program: https://sabcs.org/FullProgram

Wednesday December 11, 12:30 PM CT

Poster Session 1

Location: Halls 2-3
P1-01-05: Conducting Ancillary Studies during an Active NCTN/NCORP Screening Trial – The TMIST (ECOG-ACRIN EA1151) Experience
Presenter: Etta Pisano

Wednesday December 11, 5:30 PM CT

Poster Session 2

Location: Halls 2-3
P2-01-07: The Co-Occurrence of Obesity and Cancer-Related Fatigue and Their Combined Impact on Physical Function in a Nationwide RCT of 456 Breast Cancer Survivors (a URCC NCORP Study).
Presenter: Lindsey Mattick

Thursday December 12, 8:30 – 9:00 AM CT

Plenary Lecture

Location: Hall 1
Moderator: Virginia Kaklamani, UT Health Mays Cancer Center, San Antonio, Texas

The Grand Challenge of Unraveling Social vs Biological Drivers of Racial Disparities in Cancer Outcomes

Presenter: Melissa B. Davis, Morehouse School of Medicine, Atlanta, Georgia Cancer Grand Challenge

Thursday December 12, 9:00 – 11:45 AM CT

General Session 2

Location: Hall 1
GS2-02: Impact of Tamoxifen Only after Breast Conservation Surgery for "Good Risk" Duct Carcinoma in Situ: Results from the NRG Oncology/RTOG 9804 and ECOG-ACRIN E5194 Trial
Presenter: Jean Wright, University of North Carolina School of Medicine, Chapel Hill, North Carolina

Thursday December 12, 12:00 PM CT

Rapid Fire 2

Location: Hall 1
RF2-06: A Nationwide Double-Blind Phase III RCT Comparing Olanzapine and Prochlorperazine for Refractory Chemotherapy-Induced Nausea in NCORP Community Practices
Presenter: Luke Peppone, University of Rochester Medical Center, Rochester, New York

Friday December 13, 12:00 – 12:55 PM CT

Rapid Fire 3

Location: Hall 1
RF3-06: Mepitel Film for the Reduction of Radiation Dermatitis in Postmastectomy Radiation Therapy: Results from Alliance A221803: A Multicenter Phase III Randomized Clinical Trial
Presenter: Kimberly Corbin, Mayo Clinic, Rochester, Minnesota

Friday December 13, 12:30 – 1:45 PM CT

Roundtable discussion: Risk Reduction and Early Detection: New Directions in Breast Cancer Prevention

Location: Stars at Night 3-4
Moderator: Gretchen Gierach, National Cancer Institute, Bethesda, Maryland

Can We Use Biomarkers to Implement Prevention?

Presenter: Seema Khan, Feinberg School of Medicine of Northwestern University, Chicago, Illinois